KLRF1 and Huntington disease: In a subsequent step, we validated the incorporation of the anti-NKp80 antibody for optimal identification of total NK-cells in blood of HD and patients with different reactive or clonal NK-cell conditions, through the comparison of four different NK-cell gating strategies (Supplementary Figure S3).